Reduce the effort needed to integrate, explore and preserve your data

We provide advice, open source platforms and training to translational research projects.
eTRIKS is a project that is funded to support other projects. If you know of a project that eTRIKS could support contact us here.

consortium

eTRIKS is supporting 27 projects

and we want to support 40 by the end of 2017

Training4

We have trained over 300 researchers

Find out more about training opportunities

laboratory3

We make data curation faster and data exploration easier

Help us create new tools in eTRIKS Labs

"eTRIKS provides the gel, without which we would be floating in excess pools of data."

Ian Adcock - U-BIOPRED Work Package 6 leader

Slide Background 3

eTRIKS Standards Starter Pack is in use broadly throughout the IMI

Get the eTRIKS starter pack here


Portfolio of Resources

eTRIKS Training

eTRIKS Training
Training on the use of the eTRIKS platform to all supported partners.

Standards starter pack

Standards starter pack
Data harmonisation begins with standards.

eTRIKS Public Platform

eTRIKS Public Platform
Explore public datasets and see the eTRIKS platform in action.

Code of practice

Code of practice
Uncertain about what you can and cannot do with medical research data?



Integrated and explorable data are valuable data!


Case Studies

  • Client
    U-BIOPRED
    Date
    September 3, 2015
    Website
    View website
    Analysis pipelines for very rich data sets The Challenge OncoTrack is looking at deep data sets for cancer patients to discover new markers for Colon Cancer. The goal of OncoTrack is to identify and characterize biomarkers that will help our understanding of the variable make-up of tumours and how this affects the way patients respond to treatment. This can be used to guide appropriate therapy choices for each individual patient. The data sets created are extremely rich containing clinical data, animal xenograft data and a wide range of genomic information including GWAS and NGS. Already hundreds of terabytes of data […]
  • Client
    U-BIOPRED
    Date
    September 4, 2015
    Website
    View website
    Comparing clinical data across multiple disease areas The Challenge Biopharmaceuticals provide a valuable new approach to disease management. But a significant limitation in their use is the development of anti-drug antibodies (ADA) in some patients. The development of ADA is seen to some extent across all diseases and with all treatments, but the individual data sets for any single disease and treatment have usually been small. ABIRISK seeks to bring these data sets together to understand the common underlying causes of ADA. To do this, disparate data sets from multiple disease areas and many different institutions need to be analysed […]
  • Client
    U-BIOPRED
    Date
    September 1, 2015
    Website
    View website
    Unbiased comparison of data sets The Challenge Severe Asthma is often difficult to manage and many patients are unresponsive to treatment. Furthermore, it is thought that there are many different phenotypes of asthma that are not properly understood. U-BIOPRED aims to create ‘handprints’ that identify sub-phenotypes of asthma. The handprints can then be used to better understand the disease and lead to better targeted treatments for the individual. U-BIOPRED handprints include a wealth of diverse data on each patient and the researchers need to compare and combine them in an unbiased environment. This will permit identification of a wide range […]

Show your commitment to responsible management of medical research data


Blog

January 14, 2016
portrait4

Ghita Rahal – eTRIKS Platform Service Delivery Lead

Medical research remains largely focused on disease striation, but its quickly moving towards personalisation. Consequently, medical research data is being produced at a mind-boggling rate. Innovation in sample analysis has seen a surge in recent years; so much so affiliated domains are struggling to keep up. Biomedical analysis techniques that measure thousands of parameters simultaneously, places a huge burden on those that manage the data. It is generally accepted now that data collection will become even more extreme with the advent of validated personal health monitoring applications. Instead of hundreds or thousands of clinical study participants, we will see millions of […]
December 2, 2015
0626-I-Elliston-2-750

Keith Elliston of the tranSMART Foundation talks Datathons

You know that you are on a threshold of something special when you see experts feverously working away on something they want to test live. Data integration sounds like a relatively dull activity, but nothing could be further from the truth. Is there anything more exhilarating than discovering something that has not been seen before? Of course discovering something new that is impactful is easier said than done, but Keith Elliston, CEO of the tranSMART Foundation, has turned this into his bread and butter. Keith wants to do more than make new discoveries; he wants to change the very philosophy […]